Drug-eluting stents safe for long-term use in angioplasty patients
August 19th, 2010 - 5:53 pm ICT by ANIWashington, Aug 19 (ANI): Researchers have confirmed that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous coronary intervention (PCI), commonly known as angioplasty.
Rabin Medical Center researchers in Israel examined the benefits and long-term risks of DES by evaluating the established pattern of DES versus bare-metal stent (BMS) use in routine clinical practice.
Results showed that use of DES compared with BMS reduced the occurrence of myocardial infarction and the need for clinically driven target vessel revascularization.
Mortality was significantly lower in the DES group, showing a persistent benefit of DES over time.
Study leader Dr. Tamir Bental concludes, “The main effect of DES is reduced restenosis, which is evident in our analysis. This outcome was sustained over time and could certainly be a major factor contributing to the survival benefit of DES.”
“We suggest that a possible additional factor contributing to our results could be the pattern of use of the DES in our practice-treatment of more territories and more sites per territory, probably leading to a more complete revascularization. Another salient feature was the preferential treatment of more proximal main vessel. Therefore, treatment of proximal lesions could contribute to a better outcome,” he added.
Results of this study appear in the September issue of Catheterization and Cardiovascular Interventions. (ANI)
- Drug-eluting stents found to be superior in efficacy to bare metal stents Home - May 27, 2009
- Drug-eluting stents found to be superior in efficacy to bare metal stents - May 07, 2009
- Drug-eluting stents safer than bare-metal ones for heart patients - Sep 26, 2009
- New way to treat heart blocks: Drug eluting balloon - Sep 18, 2011
- Drug-eluting stents safer than metallic ones in preventing cardiac deaths - Mar 29, 2009
- Drug-eluting stents more effective, equally as safe as bare metal ones - Oct 16, 2008
- Everolimus-eluting stent safer, more effective than paclitaxel-eluting stent - May 06, 2010
- More strokes, fewer heart attacks with carotid stents: Study - Oct 12, 2010
- Drug-eluting stents as safe and effective than bare-metal ones - Nov 20, 2007
- Drug-coated stents less risky for heart bypass patients - Jan 22, 2009
- Drug-coated stents safer for bypass patients - Jan 22, 2009
- Drug-eluting stents safer and superior to bare metal stents - Mar 29, 2009
- Drug-eluting stent can treat coronary artery disease - Mar 14, 2009
- Drug eluting stents do make for better angioplasty outcomes - Dec 19, 2008
- Novel computer model to pave way for safer stents - Dec 03, 2009
Tags: angioplasty patients, bare metal, bental, catheterization and cardiovascular interventions, center researchers, clinical outcome, coronary intervention, myocardial infarction, preferential treatment, rabin medical center, restenosis, revascularization, routine clinical practice, salient feature, september issue, study leader, survival benefit, tamir, target, time study